However, the CD8+ T cells recruited into the tumor beds also encounter numerous barriers, including the recognition of checkpoints, such as PD-L1/PD-1, CD28/CTLA-4, and immunoglobulin-like transcript receptors (17). Here, CD274 is linked to neoplasm.